Computational revealing Infigratinib resistance to the FGFR2 N549H and N549K mutations
Fibroblast growth factor receptor 2 (FGFR2) is a receptor tyrosine kinase that is involved in many human cancers such as intrahepatic cholangiocarcinomas and hepatocellular carcinomas. The clinically acquired FGFR2 N549H/K mutations make the treatment of Infigratinib ineffective. Here, molecular doc...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Experimental Nanoscience |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/17458080.2024.2442305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!